Artificial Intelligence-Based Patient Navigator May Help Improve Disparities in Colon Cancer Screening #ASCO24
An artificial intelligence-based patient navigator tool demonstrated improved potential in helping to overcome patient attrition that can lead to colon cancer disparities, nearly doubling the rate of completed colonoscopies for…
Estrogen-Only Hormone Therapy may increase cancer risk while Estrogen-Progestin Combination may lower risk #ASCO24
For people who have been through menopause and have taken menopausal hormone therapy, conjugated equine estrogen (CEE) taken alone may increase the risk of developing and dying from ovarian cancer,…
Association Between Genital Talc Use and Increased Risk of Ovarian Cancer
A new study published in the Journal of Clinical Oncology provides compelling evidence that genital talc use is associated with an increased risk of ovarian cancer. This extensive analysis, part…
TG SALUTEDOMANI TV: VACCINE AND CANCERS, MICROPLASTICS, ELECTRONIC SKIN
ONE VACCINE, MANY CANCERS In a new study published in Blood Advances, researchers from the UChicago Pritzker School of Molecular Engineering’s Hubbell Lab created with a novel approach to develop…
One vaccine, many cancers
Acute myeloid leukemia (AML) is a type of blood cancer that forms in the soft marrow of the bones, typically attacking cells that would otherwise form the key component of…
ASCO Calls for Global Equity in Cancer Clinical Trials
A new ASCO policy statement is emphasizing the urgent need for global equity in clinical trials. The statement, which published in JCO Global Oncology, explains how global equity can be…
How does aspirin help prevent colorectal cancer development and progression?
Long-term daily use of aspirin can help to prevent the development and progression of colorectal cancer, but the mechanisms involved have been unclear. New research has revealed that aspirin may…
New urine test has higher diagnostic accuracy for prostate cancer
A new urine test that measures 18 genes associated with prostate cancer provides higher accuracy for detecting clinically significant cancers than PSA and other existing biomarker tests, according to a…
mRna, MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines
The University of Texas MD Anderson Cancer Center and CureVac N.V. today announced a co-development and licensing agreement to develop novel mRNA-based cancer vaccines. The collaboration creates strong synergies between…
Research could unlock more precise prognoses and targeted treatments for children with cancer
Researchers have identified new variations in neuroblastoma that could lead to a more accurate prognosis and better-targeted treatments for this devastating childhood cancer. A study published in theBritish Journal of…